(NHPR, STRC, AREX, CNYD, PWRM) Stock in Action by Stock-PR.com
May 09, 2011 7:35 AM ET
stock-PR.com's Blog
6 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Seeking Alpha Analyst Since 2011
<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com"; target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg"; /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835";></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085";></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup"; target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg"; width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p><span style="COLOR: black"><font color="black"><a href="nationalhealthpartners.com"; target="_blank"><strong><img style="WIDTH: 415px; HEIGHT: 39px" alt="pennyomega.com/img/nhpr.jpg"; hspace="0" src="pennyomega.com/img/nhpr.jpg"; align="bottom" border="0" mce_src="pennyomega.com/img/nhpr.jpg"; /></strong></a> <strong>National Health Partners, Inc. (OTC:NHPR)</strong><br /></font></span></p>
<p><strong>National Health Partners, Inc. (OTC:NHPR)</strong> recently announced that it has signed a new agreement with a major marketing company that will significantly enhance the growth of its CARExpress membership base.<br />
According to the Company, this deal, in combination with the previous partnership with Xpress Healthcare, will enable the company to build its membership base exponentially, initially generating in excess of an additional 2,000 new members per month. The new campaign is set to launch within the next few weeks and will provide a material positive impact on the company's 2nd quarter sales.<br />
<br />
<strong>National Health Partners</strong> anticipate that this new marketing agreement will provide a major impact on their overall sales not only for the 2nd quarter, but more importantly for the year. They look forward to building on the profits that they anticipate generating in 2011 that will be driven by substantial growth in sales of their CARExpress health discount programs. The combination of their substantial growth with their low price-to-equity ratio should reflect itself in the price of their stock over the coming months.<br />
<br />
<strong>National Health Partners, Inc</strong> primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.<br />
<br />
Xpress Healthcare has teamed up with CARExpress in an effort to revolutionize the discount healthcare industry while at the same time bringing financial freedom to families across the nation. CARExpress provides savings to its members on health services through a number of medical networks. CARExpress does not practice medicine or in any manner interfere with or participate in the provider-patient relationship. All health care decisions are between the patient and a provider.<br />
<br />
<strong>National Health Partners, Inc</strong>. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna.<br />
<br />
For more information about National Health Partners, Inc. visit its website at <a href="nationalhealthpartners.com";><font color="black">nationalhealthpartners.com<;/font></a><br />
<br />
<font color="black">**********************************************************************************<br />
<br />
<strong>SRI Surgical Express Inc. (Nasdaq:STRC)</strong> will hold its quarterly conference call to discuss first quarter results on Monday, May 9, 2011, at 5:00 p.m. Eastern Time (4 p.m. Central Time). This call is being webcast by Thomson Reuters and can be accessed at SRI's Web site at</font> <a href="srisurgical.com";><font color="black">srisurgical.com<;/font></a><font color="black">. Participants can use the following call-in information: Dial-in number is 888.680.0879 (International is 617.213.4856) passcode is 10399316. Participants can pre-register for this call at</font> <a href="www.theconferencingservice.com/prereg/ke...;><font color="black">www.theconferencingservice.com/prereg/ke...;/font></a><font color="black">. To hear a replay of this call, available from 8:00 p.m. May 9 until May 24, 2011, you can dial 888.286.8010 (International is 617.801.6888) and use passcode 95668481.<br />
<br />
SRI/Surgical Express, Inc. provides central processing and supply chain management services to hospitals and surgery centers in the United States.<br />
<br />
***********************************<br />
<br />
<strong>Approach Resources, Inc. (Nasdaq:AREX)</strong> reported financial and operating results for the first quarter of 2011. Highlights for first quarter 2011, compared to first quarter 2010, include: Total production increased 42% to 469 MBoe (5.2 MBoe/d), Oil and NGL production increased 108% to 193 MBbls, Revenues increased 53% to $20.2 million, Net income totaled $1.5 million, or $0.05 per diluted share, Adjusted net income (non-GAAP) totaled $1.2 million, or $0.04 per diluted share and EBITDAX (non-GAAP) increased 55% to $14 million, or $0.49 per diluted share.<br />
<br />
Approach Resources Inc., an independent energy company, engages in the acquisition, exploration, development, and production of unconventional natural gas and oil properties in the United States.<br />
<br />
***********************************</font></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>China Yida Holding, Co. (Nasdaq:CNYD)</strong> announced that it will conduct a conference call at 9:00 a.m. Eastern Time (ET) on Tuesday, May 10, 2011, to discuss financial results for the quarter ended March 31, 2011. Joining Dr. Minhua Chen, China Yida's Chairman and Chief Executive Officer will be Mr. George Wung, Chief Financial Officer. The Company plans to distribute its earnings press release before the call. To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-866-395-5819. International callers should dial +1-706-643-6986. The Conference ID for this call is 65092451.<br />
<br />
China Yida Holding, Co. operates as a diversified entertainment company in the People's Republic of China. The company operates in two segments, Advertisement and Tourism.<br />
<br />
************************************<br />
<br />
<strong><img style="WIDTH: 176px; HEIGHT: 76px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png"; width="152" align="bottom" border="0" /> Power3 Medical Products, Inc. (OTC:PWRM)<br /></strong><br />
<strong>Power3 Medical Products, Inc</strong>. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.<br />
<br />
BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the Power3 Medical Products' patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.<br />
<br />
There are a number of risk factors for the development of breast cancer, including: family history of breast cancer in mother or sister, abnormal breast (etc). Every woman is at risk for breast cancer. As a woman ages, her risk of developing breast cancer rises dramatically regardless of her family history. The breast cancer risk of a25-year-old woman is rare as compared to the age of 45. In fact, 80% of all breast cancers are found in women over age 50.<br />
<br />
Please visit Power3 Medical Products, Inc website</font> <a href="power3medical.com";><font color="black">power3medical.com<;/font></a><font color="black">.</font><br /></span></span></span></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40"; target="_blank"><font color="red">stock-pr.com/disclaimer<;/font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).</font></strong></span></span></p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup"; target="_blank">stock-pr.com/signup<;/a></p>
<p align="center"><a href="crownequityholdings.com"; target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg"; src="stock-pr.com/img/stock-pr_buscard.jpg"; /></a></p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com"; target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg"; /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835";></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085";></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup"; target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg"; width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p><span style="COLOR: black"><font color="black"><a href="nationalhealthpartners.com"; target="_blank"><strong><img style="WIDTH: 415px; HEIGHT: 39px" alt="pennyomega.com/img/nhpr.jpg"; hspace="0" src="pennyomega.com/img/nhpr.jpg"; align="bottom" border="0" mce_src="pennyomega.com/img/nhpr.jpg"; /></strong></a> <strong>National Health Partners, Inc. (OTC:NHPR)</strong><br /></font></span></p>
<p><strong>National Health Partners, Inc. (OTC:NHPR)</strong> recently announced that it has signed a new agreement with a major marketing company that will significantly enhance the growth of its CARExpress membership base.<br />
According to the Company, this deal, in combination with the previous partnership with Xpress Healthcare, will enable the company to build its membership base exponentially, initially generating in excess of an additional 2,000 new members per month. The new campaign is set to launch within the next few weeks and will provide a material positive impact on the company's 2nd quarter sales.<br />
<br />
<strong>National Health Partners</strong> anticipate that this new marketing agreement will provide a major impact on their overall sales not only for the 2nd quarter, but more importantly for the year. They look forward to building on the profits that they anticipate generating in 2011 that will be driven by substantial growth in sales of their CARExpress health discount programs. The combination of their substantial growth with their low price-to-equity ratio should reflect itself in the price of their stock over the coming months.<br />
<br />
<strong>National Health Partners, Inc</strong> primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.<br />
<br />
Xpress Healthcare has teamed up with CARExpress in an effort to revolutionize the discount healthcare industry while at the same time bringing financial freedom to families across the nation. CARExpress provides savings to its members on health services through a number of medical networks. CARExpress does not practice medicine or in any manner interfere with or participate in the provider-patient relationship. All health care decisions are between the patient and a provider.<br />
<br />
<strong>National Health Partners, Inc</strong>. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna.<br />
<br />
For more information about National Health Partners, Inc. visit its website at <a href="nationalhealthpartners.com";><font color="black">nationalhealthpartners.com<;/font></a><br />
<br />
<font color="black">**********************************************************************************<br />
<br />
<strong>SRI Surgical Express Inc. (Nasdaq:STRC)</strong> will hold its quarterly conference call to discuss first quarter results on Monday, May 9, 2011, at 5:00 p.m. Eastern Time (4 p.m. Central Time). This call is being webcast by Thomson Reuters and can be accessed at SRI's Web site at</font> <a href="srisurgical.com";><font color="black">srisurgical.com<;/font></a><font color="black">. Participants can use the following call-in information: Dial-in number is 888.680.0879 (International is 617.213.4856) passcode is 10399316. Participants can pre-register for this call at</font> <a href="www.theconferencingservice.com/prereg/ke...;><font color="black">www.theconferencingservice.com/prereg/ke...;/font></a><font color="black">. To hear a replay of this call, available from 8:00 p.m. May 9 until May 24, 2011, you can dial 888.286.8010 (International is 617.801.6888) and use passcode 95668481.<br />
<br />
SRI/Surgical Express, Inc. provides central processing and supply chain management services to hospitals and surgery centers in the United States.<br />
<br />
***********************************<br />
<br />
<strong>Approach Resources, Inc. (Nasdaq:AREX)</strong> reported financial and operating results for the first quarter of 2011. Highlights for first quarter 2011, compared to first quarter 2010, include: Total production increased 42% to 469 MBoe (5.2 MBoe/d), Oil and NGL production increased 108% to 193 MBbls, Revenues increased 53% to $20.2 million, Net income totaled $1.5 million, or $0.05 per diluted share, Adjusted net income (non-GAAP) totaled $1.2 million, or $0.04 per diluted share and EBITDAX (non-GAAP) increased 55% to $14 million, or $0.49 per diluted share.<br />
<br />
Approach Resources Inc., an independent energy company, engages in the acquisition, exploration, development, and production of unconventional natural gas and oil properties in the United States.<br />
<br />
***********************************</font></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>China Yida Holding, Co. (Nasdaq:CNYD)</strong> announced that it will conduct a conference call at 9:00 a.m. Eastern Time (ET) on Tuesday, May 10, 2011, to discuss financial results for the quarter ended March 31, 2011. Joining Dr. Minhua Chen, China Yida's Chairman and Chief Executive Officer will be Mr. George Wung, Chief Financial Officer. The Company plans to distribute its earnings press release before the call. To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-866-395-5819. International callers should dial +1-706-643-6986. The Conference ID for this call is 65092451.<br />
<br />
China Yida Holding, Co. operates as a diversified entertainment company in the People's Republic of China. The company operates in two segments, Advertisement and Tourism.<br />
<br />
************************************<br />
<br />
<strong><img style="WIDTH: 176px; HEIGHT: 76px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png"; width="152" align="bottom" border="0" /> Power3 Medical Products, Inc. (OTC:PWRM)<br /></strong><br />
<strong>Power3 Medical Products, Inc</strong>. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.<br />
<br />
BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the Power3 Medical Products' patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.<br />
<br />
There are a number of risk factors for the development of breast cancer, including: family history of breast cancer in mother or sister, abnormal breast (etc). Every woman is at risk for breast cancer. As a woman ages, her risk of developing breast cancer rises dramatically regardless of her family history. The breast cancer risk of a25-year-old woman is rare as compared to the age of 45. In fact, 80% of all breast cancers are found in women over age 50.<br />
<br />
Please visit Power3 Medical Products, Inc website</font> <a href="power3medical.com";><font color="black">power3medical.com<;/font></a><font color="black">.</font><br /></span></span></span></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40"; target="_blank"><font color="red">stock-pr.com/disclaimer<;/font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).</font></strong></span></span></p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup"; target="_blank">stock-pr.com/signup<;/a></p>
<p align="center"><a href="crownequityholdings.com"; target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg"; src="stock-pr.com/img/stock-pr_buscard.jpg"; /></a></p>
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.